AstraZeneca turned up the pressure in its head-to-head battle with GlaxoSmithKline in the asthma arena yesterday, after winning approval for a new dosing regimen for its combination product Symbicort.

WASHINGTON, Jan. 11 (UPI) -- The anticipated approval of a new dosing regimen for AstraZeneca's Symbicort in Europe could significantly alter the asthma drug market, analysts said Wednesday. The ...

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...

Shares in Anglo-Swedish drugmaker AstraZeneca were in the ascendancy this morning after it revealed that its combination drug for asthma, Symbicort, had been approved in the USA. Shares in ...

The studies examined the efficacy of Symbicort pressurized metered dose inhaler (pMDI) 160/4.5mcg vs. formoterol 4.5mcg in reducing COPD exacerbations in adults with moderate to severe COPD. The FDA ...

The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence. The Food and Drug Administration (FDA) has granted Adherium ...

Viatris’ new drug-device is the first FDA-approved generic version of AstraZeneca’s Symbicort. Kindeva Drug Delivery, a contract development and manufacturing organization, and Viatris announced FDA ...

GlaxoSmithKline and Innoviva’s triple-combination therapy of fluticasone furoate, umeclidinium and vilanterol significantly reduced the amount of exacerbations experienced by patients with chronic ...